Background
==========

It has been well documented that overweight and obesity is now a global epidemic with relatively few countries unaffected. The World Health Organisation (WHO) has estimated that 1.6 billion people are overweight worldwide, which, for the first time, exceeds those who are undernourished \[[@B1],[@B2]\]. Moreover, low- and middle-income countries, such as China that traditionally had one of the leanest populations, are rapidly approaching the prevalence of overweight observed in more developed regions \[[@B3]\]. Although the prevalence of smoking in the Western world has progressively declined over the past forty years -- due largely to effective and comprehensive tobacco control measures -- tobacco consumption remains high in many countries across Asia where about 40--70% of men smoke \[[@B4]\]. This is a likely consequence of the low level of awareness of the health hazards associated with smoking combined with a low use of smoking cessation aids and aggressive promotion of smoking by the tobacco industry in many countries in Asia, such as China \[[@B5]\].

Smoking \[[@B6]-[@B8]\] and excess weight \[[@B9]-[@B11]\] are well established risk factors for cardiovascular disease. In smokers, the risk of coronary heart disease (CHD) and stroke is more than twice that of non-smokers \[[@B7]\], whereas there is a somewhat more modest increase in risk associated with overweight and obesity \[[@B11]\]. Some previous studies have suggested that the association between body mass index (BMI) and cardiovascular risk may be modified by smoking, although there is dispute over whether smoking amplifies or attenuates the relationship \[[@B12]-[@B15]\]. If smoking does interact with BMI, this would have ramifications for estimates of disease burden due to these two important and modifiable risk factors, and have implications for disease prevention. In the present study, we take advantage of the Asia Pacific Cohort Studies Collaboration (APCSC) -- a large database comprising more than 40 longitudinal studies from the region -- to explore this important public health issue.

Methods
=======

Participating studies
---------------------

The APCSC is an individual participant data overview conducted by the principal investigators of 44 existing cohort studies in the region. Methods of study identification, their characteristics have been reported elsewhere \[[@B16],[@B17]\]. In brief, studies were eligible for inclusion in the project if they satisfied the following criteria: (1) a study population from the Asia Pacific region; (2) prospective study design; (3) at least 5,000 person-years of follow-up recorded; (4) date of birth (or age), sex, and blood pressure recorded at baseline; (5) date of death (or age at death) recorded during follow-up. Additionally, for analyses in this report, participants were restricted to individuals aged 20 years or over at study entry with information on both BMI and smoking status.

Measurement of baseline variables
---------------------------------

Height and weight were measured using standard protocols when the participant entered the study, and BMI was calculated as weight (kg) divided by squared height (m^2^). Cigarette smoking status (current smoker/non-smoker) at baseline was assessed on the basis of self-report. Whether an individual was a current smoker, a former smoker or a never smoker was also reported in a smaller number of studies. Cohorts were classified as Asian if the participants were recruited from Mainland China, Hong Kong, Japan, Korea, Singapore, Taiwan or Thailand and as Australasian (ANZ) if the participants were from Australia or New Zealand. This classification largely represented a split by ethnicity into Asians and non-Asians.

Outcomes
--------

Outcomes included in this report were total (fatal and non-fatal) coronary heart disease (CHD), total ischaemic stroke, total haemorrhagic stroke (primary intracerebral haemorrhage and subarachnoid haemorrhage) and unclassified stroke. Non-fatal events were defined as those that did not result in death within 28 days. Outcomes were coded according to the Ninth Revision of the International Classification of Diseases (ICD-9): Combined fatal and non-fatal CHD events (ICD-9: 410 -- 414) and stroke events \[total stroke (ICD-9: 430--438); haemorrhagic stroke (431.0--432.9); and ischaemic stroke (433.0--434.9)\]. Since most studies used record linkage with official sources, verification of strokes was not routinely reported. However, 12 of the 36 studies included in this analysis provided information on stroke verification, and in 6 of them (n = 155252) a pathological subtype of stroke was determined by CT/MRI scan or brain autopsy in over 75% of stroke cases (n = 2448). All data provided to the Secretariat were checked for completeness and consistency and re-coded where necessary to maximise comparability across cohorts. Summary reports were referred back to principal investigators of each collaborating study for review and confirmation.

Statistical methods
-------------------

Participants at extreme ends of the BMI spectrum (i.e., \<15 or \>50 kg/m^2^) were excluded from the analysis (n = 303). To address the possibility of reverse causality whereby a low BMI may be indicative of some occult disease, all HRs (95% Confidence Intervals \[95% CI\]) reported in the results are derived after three years left-censoring of the data. Having ascertained that the proportional hazards assumption had not been violated, Cox proportional hazards regression models were used to regress time until first CHD or stroke event against levels of baseline BMI by smoking status (current smoker or non-smoker) \[[@B18]\]. All analyses were adjusted for age and stratified by study and sex. Further, to consider the potential effects of smoking on the relationships between BMI, CHD and stroke, independent of intermediary variables along the causal pathway between adiposity and cardiovascular outcomes we additionally adjusted for systolic blood pressure (SBP). We repeated these analyses within the sub-group of participants on whom information on all intermediary variables including SBP, serum total cholesterol (TC) and diabetic status were available. To explore log-linearity of the associations between BMI and CHD and stroke events, HRs were plotted for mean level in each of five BMI categories (the penultimate lowest category was the referent). For HRs in each category, 95% CIs were estimated by the \'floating absolute risk\' method \[[@B19]\].

HRs with 95% CIs were also calculated for a 2 kg/m^2^higher BMI as a continuous variable. Further HRs (95% CIs) were calculated comparing the effects of smoking status in individuals classified either as overweight (BMI ≥ 25 kg/m^2^in ANZ and BMI ≥ 24 kg/m^2^in Asia) or \"normal\" weight (BMI ≤ 25 kg/m^2^in ANZ and BMI ≤ 24 kg/m^2^in Asia \[[@B20]\]. The statistical significance of any interaction between BMI and smoking status was assessed using likelihood ratio tests, comparing the models with main effects only with the models that included the interaction term \[[@B21]\]. As well as analyses of the overall APCSC, pre-defined subgroup analyses were performed by sex, by region (Asia and ANZ) and by age at risk (restricted to the following age-groups: 35 -- 59, 60 -- 69, 70 -- 79, 80 -- 89 years).

Analyses were repeated on the sub-sample of the total population which had information on whether any non-smoker had previously smoked. In these sub-samples, participants were classified as \'current\' if they smoked currently, \'never smokers\' if they had never smoked and \'former smokers\' if they had smoked but reported having already quit at study baseline. HRs for a 2 kg/m^2^higher level of BMI were estimated for each of these smoking groups, and compared using similar methods to the main analyses.

Results
=======

Characteristics of the study population
---------------------------------------

Information on BMI and smoking status (current smoker or not) was available from 38 cohorts (86% of all studies in APCSC); 30 from Asia (Table [1](#T1){ref-type="table"}). Overall, 378,579 participants were included in the analysis (76% Asians; 40% female) with a mean age of 47 years. Approximately one-third (34%) of study participants were classified as current smokers at baseline, with marked differences by sex and region: in Asia, 60% of men and 5% of women were current smokers, compared to 21% and 14%, respectively, in ANZ. In Asia, mean age and BMI were similar between smokers and non-smokers (46 versus 46 years; 22.8 versus 22.9 kg/m^2^), but in ANZ, current smokers were younger (47 years versus 53 years) and had a lower BMI (25.6 kg/m^2^versus 26.4 kg/m^2^) than non-smokers. Of the 38 cohorts included in the main analyses, 32 (24 in Asia) recorded former smoking status for non-smokers. Of 339,251 participants in these cohorts, approximately 17% were former smokers, 50% were never smokers and 32% were current smokers. In Asian cohorts, 23% of men and 23% of women who had ever smoked had quit, compared to 66% and 59%, respectively, in ANZ.

###### 

Study population characteristics at baseline by smoking status

                             Non-smokers   Current smokers                                                                                           
  -------------------------- ------------- ----------------- --------------- -------- ----- ------------- --------------- -------- ---- ------ ----- -----
                                           Age (years)       BMI (kg/m^2^)   Female         Age (years)   BMI (kg/m^2^)   Female                     
  Study name                 n             mean              SD              mean     SD    (%)           n               mean     SD   mean   SD    (%)
                                                                                                                                                     
  Akabane                    1294          55                8               22.7     3.1   77            499             53       7    22.0   2.6   2
  Anzhen                     5778          54                13              24.1     3.7   70            2306            52       12   23.4   3.4   20
  Anzhen02                   2995          47                8               23.9     3.3   65            733             46       8    24.1   3.1   1
  Beijing Aging              1281          69                8               24.0     3.9   63            545             68       8    22.4   3.7   24
  Capital Iron & Steel Co.   1281          45                8               23.7     2.7   0             3570            45       8    23.0   2.7   0
  CISCH                      1535          44                7               24.6     3.5   70            572             45       8    24.6   3.1   2
  Civil Service Workers      5614          47                5               22.5     2.7   47            3401            47       5    22.4   2.8   10
  CVDFACTS                   4188          47                15              23.5     3.4   71            1192            48       15   23.5   3.2   4
  East Beijing               756           44                15              23.7     3.2   65            318             41       15   23.5   3.4   19
  EGAT                       1786          42                5               23.2     3.1   38            1315            43       5    22.8   3.1   3
  Fangshan                   842           47                11              24.6     3.4   87            556             48       10   23.2   3.3   37
  Guangzhou Occupational     10534         42                6               22.8     3.0   61            9876            43       6    22.2   2.7   1
  Hisayama                   793           56                11              21.8     2.8   82            600             54       9    21.4   2.4   23
  Hong Kong                  637           78                6               22.5     3.7   74            164             75       5    21.1   3.4   40
  Kinmen                     121           67                11              23.5     3.5   67            56              67       10   22.4   4.1   18
  KMIC                       97831         44                7               22.9     2.5   54            60711           45       7    23.3   2.4   0
  Konan                      719           52                16              22.1     3.1   76            310             50       15   21.7   2.8   8
  Miyama                     688           60                9               22.4     3.0   74            297             60       9    21.7   2.7   13
  Ohasama                    1704          59                11              23.5     3.2   78            423             57       12   22.5   2.9   8
  Saitama                    2527          54                12              22.5     2.9   80            1001            54       12   22.0   2.8   17
  Seven Cities Cohorts       3201          54                12              21.9     3.1   70            1809            53       12   20.8   2.8   22
  Shibata                    1472          56                11              22.8     3.2   83            730             56       10   21.8   2.6   8
  Shigaraki Town             1742          58                14              22.8     3.1   77            711             56       13   21.8   2.8   13
  Shirakawa                  2989          48                12              21.6     2.8   79            1586            48       12   21.2   2.5   8
  Singapore Heart            1768          40                13              23.8     4.4   61            495             41       14   22.8   4.0   7
  Singapore NHS92            2649          39                12              23.3     4.1   62            594             38       12   22.9   4.2   8
  Six Cohorts                10359         44                7               21.3     2.7   77            8804            45       7    21.1   2.4   12
  Tanno/Soubetsu             1183          51                7               24.1     3.2   78            737             51       7    22.9   2.9   14
  Tianjin                    4254          55                12              24.4     4.0   65            4438            53       11   23.0   3.7   39
  Yunnan                     1979          57                10              22.0     3.0   10            4263            54       9    21.4   2.8   0
  **Total Asia**             174500        46                10              22.9     2.9   59            112612          46       9    22.8   2.8   5
                                                                                                                                                     
  ALSA                       871           77                6               26.3     4.0   51            60              76       5    24.9   4.3   52
  ANHF                       6932          44                13              25.5     4.3   53            2184            41       13   25.1   4.2   45
  Busselton                  4729          45                17              24.8     3.9   60            2450            43       16   24.2   3.6   37
  Fletcher Challenge         7673          45                15              26.4     4.1   30            2362            40       12   26.5   4.3   22
  Melbourne                  36235         55                9               26.9     4.4   61            4561            53       8    26.6   4.3   48
  Newcastle                  4484          52                11              26.9     4.5   54            1324            49       10   25.9   4.3   41
  Perth                      7561          46                13              25.3     3.9   51            2569            43       12   24.7   3.8   40
  WAAAAS                     6707          72                4               26.9     3.6   0             765             71       4    26.0   4.0   0
  **Total ANZ**              75192         53                14              26.4     4.3   50            16275           47       14   25.6   4.2   38
                                                                                                                                                     
  **Total**                  249692        48                11              24.0     3.8   56            128887          46       10   23.1   3.1   9

BMI, body mass index; SD, standard deviation; ANZ, Australia and New Zealand; ALSA, Australian Longitudinal Study of Aging; ANHF, Australian National Heart Foundation; CISCH, Capital Iron and Steel Company Hospital; EGAT, Electricity Generating Authority of Thailand; KMIC, Korean Medical Insurance Corporation; NHS92, National Health Study 1992, WAAAAS, Western Australian AAA Screenees. Blanks indicate that the event was not reported for that study.

Follow-up and outcomes
----------------------

In total, there were 1,431,261 person-years of follow-up; the mean follow-up was 3.8 years (3.9 years for current smokers and 3.6 years for non-smokers) but it was shorter, for both current smokers and non-smokers, in Asia (2.9 and 2.8 years, respectively) than in ANZ (8.3 and 6.3 years) (Table [2](#T2){ref-type="table"}). In addition to information on fatal events that was available from all cohorts, data on non-fatal events were present in 18 studies (Table [2](#T2){ref-type="table"}). During follow-up there were 2706 CHD events (33% in Asia), of which myocardial infarction accounted for more than 80%, and 3264 stroke events (70% in Asia).

###### 

Fatal and non-fatal coronary heart disease and stroke events by smoking status after three years left-censoring

                                Number of events (female %)                                                                                              
  ----------------------------- ----------------------------- -------------- -------------- -------------- --------------- -------------- -------------- --------------
  Asia                                                        272 (58)       180 (71)       445 (50)       262 (15)        268 (13)       165 (15)       458 (7)
  (2.7 M, 3.1 F)                                              360 (53)       428 (59)       300 (65)       420 (12)        345 (11)       464 (10)       207 (8)
   Fatal events                 274 (59)                                                                                                                 
   Fatal and non-fatal events   369 (53)                                                                                                                 
  ANZ                                                         64 (48)        49 (57)        511 (52)       451 (23)        26 (31)        12 (8)         265 (37)
  (6.1 M, 7.5 F)                                              93 (50)        197 (52)       525 (54)       638 (24)        50 (34)        90 (34)        233 (37)
   Fatal events                 983 (40)                                                                                                                 
   Fatal and non-fatal events   1279 (40)                                                                                                                
                                                                                                                                                         
  **Total events**              **1648 (43)**                 **453 (52)**   **625 (57)**   **825 (58)**   **1058 (20)**   **395 (14)**   **554 (14)**   **447 (24)**

ANZ = Australia and New Zealand; M = male; F = female; CHD = coronary heart disease; Haem = haemorrhagic stroke; Isch = ischaemic stroke; NA = unclassified stroke

The association between BMI and CHD in current and non-smokersHigher levels of BMI were positively and log-linearly associated with the risk of incurring a fatal or non-fatal CHD event, irrespective of smoking status (Table [3](#T3){ref-type="table"}). There was strong evidence that compared with non-smokers, smoking amplified the strength of the association between BMI with CHD; this was apparent irrespective of whether BMI was dichotomised into \"normal\" and \"overweight\" or measured on a continuous scale. For example, current smokers who were overweight (25 \< BMI ≤ 29.9 kg/m^2^in ANZ and 24 ≤ BMI ≤ 28 kg/m^2^in Asia) had approximately one-third greater excess risk of CHD compared with overweight (BMI \> 30 kg/m^2^in ANZ and BMI \> 28 kg/m^2^in Asia) non-smokers: HR 1.64 (95% CI: 1.47 -- 1.82) vs. 1.47 (95% CI: 1.36 -- 1.59); p-value for interaction = 0.019 (Table [3](#T3){ref-type="table"}). Similarly, for a 2 kg/m^2^increment in BMI, the excess risk for CHD was greater in current smokers than in non-smokers by approximately four percentage points (i.e., 13% versus 9%) (Figure [1a](#F1){ref-type="fig"}): HR 1.13 (95% CI: 1.10 -- 1.17) versus HR 1.09 (95% CI: 1.06 -- 1.11); p-value for interaction = 0.04. When fatal CHD events alone (n = 1970) were analysed, similar patterns were observed: HR (95% CI) for a 2 kg/m^2^higher BMI was 1.14 (1.09 -- 1.18) for current smokers and 1.09 (1.06 -- 1.12) for non-smokers; p-value for interaction = 0.07.

###### 

Adjusted hazard ratios (HRs) (with 95% confidence intervals) for the relationship between BMI with CHD in non- and current smokers in data that had been left-censored by three years

  Smoking Status   BMI category (kg/m^2^)   Mean BMI (kg/m^2^)   No. of events   Age, sex, study adjusted HR for combined fatal and non-fatal CHD (95% CI)\*   Age, sex, study adjusted HR (95% CI) for fatal CHD\*\*
  ---------------- ------------------------ -------------------- --------------- ----------------------------------------------------------------------------- --------------------------------------------------------
  Non              15.0 -- 18.4             17.6                 46              1.31 (0.97 -- 1.77)                                                           1.34 (0.96 -- 1.86)
                   18.5 -- 21.9             20.5                 201             1.00 (0.87 -- 1.15)                                                           1.00 (0.85 -- 1.18)
                   22.0 -- 24.9             23.4                 457             1.34 (1.22 -- 1.47)                                                           1.40 (1.26 -- 1.56)
                   25.0 -- 29.9             26.8                 699             1.47 (1.36 -- 1.59)                                                           1.49 (1.36 -- 1.63)
                   30.0 -- 50.0             33.1                 245             1.83 (1.61 -- 2.09)                                                           1.90 (1.63 -- 2.20)
                                                                                                                                                               
  Current          15.0 -- 18.4             17.6                 29              0.73 (0.50 -- 1.06)                                                           0.84 (0.56 -- 1.24)
                   18.5 -- 21.9             20.5                 237             1.00 (0.88 -- 1.14)                                                           1.00 (0.85 -- 1.17)
                   22.0 -- 24.9             23.4                 326             1.22 (1.10 -- 1.36)                                                           1.15 (1.01 -- 1.32)
                   25.0 -- 29.9             26.6                 362             1.64 (1.47 -- 1.82)                                                           1.49 (1.30 -- 1.70)
                   30.0 -- 50.0             32.6                 104             2.05 (1.68 -- 2.51)                                                           2.22 (1.76 -- 2.79)

\*P-value for interaction between never and current smokers = 0.019

\*\* P-value for interaction between never and current smokers = 0.08

![**Hazard ratios (HRs) associated with a 2 kg/m^2^higher body mass index for coronary heart disease events in current smokers and non-smokers, by sex, region, age and overall**. Analyses are adjusted by age and stratified by study and sex. The horizontal lines (or widths of diamonds for overall results) show 95% confidence intervals (CIs). The p values shown are for the test of interaction between body mass index and smoking status. The dashed and continuous lines represent current smokers and non-smokers, respectively.](1471-2458-9-294-1){#F1}

After adjustment for SBP the relationship between BMI and CHD was weakened but the interaction with smoking remained significant (p = 0.19). In the sub-group of individuals in whom data were available for SBP, TC and diabetes status (n = 318,384 and 2446 CHD events) there was no evidence of an interaction between smoking and BMI on subsequent risk of CHD before, or after, adjustment for these variables (p = 0.22 and p = 0.21, respectively), which is potentially due to the reduced power to detect any interaction.

The pattern of a stronger association between BMI and CHD among smokers compared with non-smokers was broadly consistent across the age, sex and region subgroups, although the test for interaction was non-significant in each of the sub-groups examined (Figure [1](#F1){ref-type="fig"}). There was some suggestion that the interaction was only apparent in individuals aged \> 65 years (Figure [1](#F1){ref-type="fig"}). When we further stratified individuals into four age groups (35--59, 60--69, 70--79 and 80--89 yrs), the effect of a 2 kg/m^2^increment in BMI on CHD was identical in smokers and non-smokers in the youngest age-group (HR 1.16 95% CI: 1.09 -- 1.22) whereas in the other three groups, the HRs were consistently stronger in smokers compared with non-smokers (results not shown but available on request).

In the sub-sample of studies for which information on former smokers was available, there were 2513 CHD events. The excess risk for CHD associated with a 2 kg/m^2^higher BMI was greater in current smokers than in former smokers and never smokers: HR 1.13 (95% CI: 1.09 -- 1.17) versus 1.10 (1.06 -- 1.14) and 1.08 (1.04 -- 1.11), respectively (p-value for interaction = 0.10).

The association between BMI and stroke risk in current and non-smokers
----------------------------------------------------------------------

As with CHD, irrespective of smoking status, BMI was positively and log-linearly associated with the risk of ischaemic stroke, and to a lesser extent, haemorrhagic stroke and \'unclassified\' stroke. When comparing the magnitude of the association between BMI and stroke risk, there was no evidence of an interaction with smoking for either ischaemic or haemorrhagic stroke: For a 2 kg/m^2^higher BMI, the HRs (95% CI) in smokers compared with non-smokers for ischaemic and haemorrhagic stroke were: 1.09 (1.04 -- 1.15) vs 1.11 (1.06 -- 1.16), p for interaction = 0.66; and 1.08 (1.02 -- 1.15) vs. 1.08 (1.03 -- 1.14), p for interaction = 0.95 (Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). In sensitivity analyses, there was no evidence to indicate an interaction between smoking and BMI by age group, sex or region for either ischaemic or haemorrhagic stroke (all p-values \> 0.10). Restriction of the analyses to only fatal stroke events did not alter these findings.

![**Hazard ratios (HRs) associated with a 2 kg/m^2^higher body mass index for ischaemic stroke events in current smokers and non-smokers, by sex, region, age and overall**. Analyses are adjusted by age and stratified by study and sex. The horizontal lines (or widths of diamonds for overall results) show 95% confidence intervals (CIs). The p values shown are for the test of interaction between body mass index and smoking status. The dashed and continuous lines represent current smokers and non-smokers, respectively.](1471-2458-9-294-2){#F2}

![**Hazard ratios (HRs) associated with a 2 kg/m^2^higher body mass index for haemorrhagic stroke events in current smokers and non-smokers, by sex, region, age and overall**. Analyses are adjusted by age and stratified by study and sex. The horizontal lines (or widths of diamonds for overall results) show 95% confidence intervals (CIs). The p values shown are for the test of interaction between body mass index and smoking status. The dashed and continuous lines represent current smokers and non-smokers, respectively.](1471-2458-9-294-3){#F3}

For those strokes that were unclassified there was marginal evidence of an interaction between BMI and smoking, but in the opposing direction to that observed with CHD (Figure [4](#F4){ref-type="fig"}). The HRs (95% CI) associated with a 2 kg/m^2^higher BMI in smokers compared with non-smokers were 1.02 (0.97 -- 1.07) vs 1.08 (1.04 -- 1.12), p for interaction = 0.08. The apparent stronger effect of BMI on risk of unclassified stroke in non-smokers was observed in several of the subgroups. For example, in men, the HRs (95% CIs) for the risk of unclassified stroke associated with a 2 kg/m^2^higher BMI were 1.12 (1.06 -- 1.19) for non-smokers and 0.99 (0.93 -- 1.06) for smokers; p for interaction 0.005 (Figure [4](#F4){ref-type="fig"}).

![**Hazard ratios (HRs) associated with a 2 kg/m^2^higher body mass index for unclassified stroke events in current smokers and non-smokers, by sex, region, age and overall**. Analyses are adjusted by age and stratified by study and sex. The horizontal lines (or widths of diamonds for overall results) show 95% confidence intervals (CIs). The p values shown are for the test of interaction between body mass index and smoking status. The dashed and continuous lines represent current smokers and non-smokers, respectively.](1471-2458-9-294-4){#F4}

Discussion
==========

This pooled analysis including information on more than 370,000 people confirms the positive log-linear relationship between BMI and CHD and stroke risk in both smokers and never smokers, with no evidence of a threshold effect within BMIs greater than 18.5 kg/m^2^. Additionally, there was some suggestion that the relationship between BMI and risk of CHD is amplified by the effects of smoking, such that the excess risk for CHD associated with being overweight in smokers was more than double that of non-smokers. There was also some evidence to indicate that the amplification effect of smoking is reversible subsequent to quitting smoking. These findings are consistent with previous work from our group, which have reported that smoking may potentiate the effects of other cardiovascular risk factors for CHD, including total cholesterol \[[@B21]\]. In contrast, there was no evidence to indicate that smoking amplifies the relationship between BMI with either ischaemic or haemorrhagic stroke. Anomalous to this finding was the indication that the relationship between BMI with risk of unclassified stroke may actually be stronger among non-smokers compared with current smokers. However, this observation should be treated more cautiously given the subgroup nature of this analysis, the lack of complete information on the type of stroke event and the finding of no interaction between BMI and smoking with either of the major stroke subtypes that are sure to constitute most of the unclassified strokes.

Comparison with other studies
-----------------------------

Earlier findings on this issue are conflicting. Although there are confirmatory data from previous studies, there are also several large studies that either reported no interaction or a slightly weaker association between BMI and CHD in smokers compared with non-smokers. For example, in a prospective cohort of 220,000 Chinese men, in whom there were 1240 deaths from ischaemic heart disease, Chen et al. observed a similar excess risk of CHD associated with 2 kg/m^2^increment in BMI in never and ever smokers \[[@B15]\]: 1.13 (95% CI: 0.98 -- 1.30) and 1.12 (1.02 -- 1.22) respectively; p for heterogeneity = 0.9. Similarly, in the INTERHEART case-control study there was no evidence of a significant interaction between BMI and smoking on the risk of myocardial infarction (MI) in never, former and current smokers: age and sex-adjusted odds ratios (95% CI) for MI for 1 SD increase in BMI were 1.12 (1.08 -- 1.17), 1.13 (1.06 -- 1.19) and 1.17 (1.11 -- 1.22), respectively \[[@B22]\]. Whereas, in contrast to our study, the Nurses\' Health Study in the Unites States \[[@B23]\], as well as other cohort studies from Western countries \[[@B14]\], observed a rather weaker positive association between BMI and CHD in current smokers compared to non-smokers or never smokers, although formal tests for interaction were not performed. For example, in the Nurses\' Health Study, the relative risk for CHD comparing women with BMI ≥ 29 kg/m^2^to those with BMI \< 21 kg/m^2^was 3.26 (95% CI: 2.58 -- 4.12) in current smokers compared with 4.36 (95% CI: 3.12 -- 6.09) in never or former smokers \[[@B23]\].

The reasons for these discrepant findings are unclear, but may be due to differences in the age, sex and smoking characteristics of the populations studied or, alternatively, to random noise given that the size of any interaction between BMI and smoking is likely to be relatively small. Consequently, in order to be able to reliably detect any effect it would require a sufficiently large sample size and a diversity of study populations, both are key strengths of the current analysis. Differences in how smoking is quantified between studies, length of follow-up and the suggestion of an interaction that is only apparent in men \[[@B13]\] may also explain some of the heterogeneity in study findings. The present study is also not without its limitations, one of which is the lack of information on changes in BMI and smoking status during follow-up. However, any potential changes, particularly those relating to smoking (for example, quitting smoking during follow-up) would have resulted in an underestimation of the synergistic relationship between BMI and smoking. Moreover, we had limited, or no, data on both the quantity of cigarettes smoked and the duration of smoking, which are both key determinants of the magnitude of the smoking hazard. Furthermore, we were limited to using BMI, a measure of general adiposity, whereas central adiposity is considered to be more closely associated with metabolic disorders than general obesity \[[@B24]\]. We had limited information on waist circumference and waist to hip ratio, which are better indicators of central obesity. As current smokers have been reported to have a higher abdominal fat distribution profile, in spite of their lower BMI, compared to never smokers \[[@B25],[@B26]\], it may be that the effects of smoking are more apparent if indices of central obesity are used \[[@B26]-[@B28]\].

Excess weight is indirectly, and possibly directly, associated with CHD through its adverse effects on blood pressure, lipids and glucose metabolism \[[@B29],[@B30]\]. These known coronary risk factors promote atherosclerosis of the coronary arteries in the causal pathway between adiposity and CHD. One possible pathophysiological explanation for the observed synergism is that smoking and one or more of the adiposity-induced metabolic disorders may interact to promote coronary atherosclerosis. Alternatively, smoking may affect another as yet unknown pathway between excess weight and CHD risk independent of known metabolic abnormalities.

Conclusion
==========

In conclusion, our data re-emphasize the importance of appropriate lifestyles and risk factor management for the prevention of CHD. Even though the amplification effect of smoking on the BMI-CHD relation is relatively small, given the widespread prevalence of smoking and excess weight (1 billion and 1.7 billion people, respectively), the population attributable risk is considerable. Thus, strategies to curb both smoking and promote weight loss at the population level could have a greater impact on reducing the burden of CHD than previously anticipated.
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